Cingulate

Cingulate Interest Coverage

The Interest Coverage Ratio of Cingulate (CING) as of Nov 11, 2026 is -157.71. In the previous year, Interest Coverage Ratio was -29.35 — a change of 437.42% (lower).

Interest Coverage

-157.71

YoY

437.42%

Last updated:

Interest Coverage Ratio of Cingulate is 2024 -157.71 . Interest Coverage Ratio of Cingulate was 2023 -29.35 . It decreases by 437.42% lower compared to the previous year.

The Cingulate Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2019
-116.47 USD
Jan 1, 2020
-70.83 USD
Jan 1, 2021
-689.32 USD
Jan 1, 2022
-102.95 USD
Jan 1, 2023
-29.35 USD
Jan 1, 2024
-157.71 USD
The Cingulate Interest Coverage history
YEARInterest CoverageYoY
-157.71+437.42%
-29.35-71.50%
-102.95-85.06%
-689.32+873.15%
-70.83-39.18%
-116.47—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Interest Coverage Ratio of Cingulate is -157.71 in 2024.

Interest Coverage Ratio of Cingulate changed from -29.35 to -157.71, representing a 437.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Cingulate since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Cingulate with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Cingulate

All Key Metrics — Cingulate